New award for fluticasone/salmeterol inhalers with glaxosmithkline. Ordering period is august 1, 2026 - july 31, 2027 WIT four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0030
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Fluticasone/Salmeterol Inh Powder Pre-Solicitation · 36E79726R0009 · Posted Feb 2, 2026
- Last date to order 21% complete
- IDV ceiling
- $182,885,823.60
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded an indefinite-delivery contract to Glaxosmithkline, LLC for Fluticasone/Salmeterol inhalers on August 1, 2026, with a ceiling value of $182,885,823.60. This is a single-award contract with no set-aside used.
The contract supplies multiple federal agencies including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. Inhalers are distributed through the VA's and DoD's Pharmaceutical Prime Vendor Programs.
The originating solicitation (Solicitation #36E79726R0009) required submission of exact drug name and strength, a unique 11-digit NDC number specific to the contractor's company, and certification of completed stability testing. All inhalers must be individually boxed with barcodes and compatible with automated dispensing units. The procurement specified three strength configurations in 60-dose form (30-day supply): Fluticasone 100mcg/Salmeterol 50mcg (approximately 317,019 canisters annually), 250mcg/50mcg (approximately 1,479,360 canisters annually), and 500mcg/50mcg (approximately 504,192 canisters annually).
The contract period runs August 1, 2026 through July 31, 2027, with four one-year options. The contract incorporates Section 5 of Executive Order 14398 and FAR Clause 52.222-90, addressing discrimination concerns. NAICS classification is 325412 (Pharmaceutical Preparation Manufacturing).
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0030?
36E79726D0030 was awarded to Glaxosmithkline, LLC by National Acquisition Center (Headquarters) on August 1, 2026.
How much is contract 36E79726D0030 worth?
36E79726D0030's own ceiling is $182,885,824.
Who can order from contract 36E79726D0030?
36E79726D0030 is a single award indefinite delivery contract.
Was contract 36E79726D0030 competed?
The extent of competition for 36E79726D0030 was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV